Cargando…

Prevalence and associated risk factors of diabetic retinopathy and macular oedema in patients recently diagnosed with type 2 diabetes

OBJECTIVE: To determine the prevalence of diabetic retinopathy (DR) and diabetic macular oedema (DME) and their associated risk factors in patients recently diagnosed with type 2 diabetes. METHODS AND ANALYSIS: We carried out a cross-sectional study from April 2014 to August 2017. We included patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Graue-Hernandez, Enrique O, Rivera-De-La-Parra, David, Hernandez-Jimenez, Sergio, Aguilar-Salinas, Carlos A, Kershenobich-Stalnikowitz, David, Jimenez-Corona, Aida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066603/ https://www.ncbi.nlm.nih.gov/pubmed/32201732 http://dx.doi.org/10.1136/bmjophth-2019-000304

Ejemplares similares

Disparities in prediabetes and type 2 diabetes prevalence between indigenous and nonindigenous populations from Southeastern Mexico: The Comitan Study
por: Jimenez-Corona, Aida, et al.
Publicado: (2019)

Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City
por: Hernández-Jiménez, Sergio, et al.
Publicado: (2021)

Cost of diabetic retinopathy and macular oedema in a population, an eight year follow up
por: Romero-Aroca, Pedro, et al.
Publicado: (2016)

Correction: Diabetic retinopathy and diabetic macular oedema pathways and management: UK Consensus Working Group
por: Amoaku, Winfried M., et al.
Publicado: (2020)

Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema
por: Foos, William F, et al.
Publicado: (2022)

Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review
por: Poku, Edith, et al.
Publicado: (2013)

Indicators of Visual Prognosis in Diabetic Macular Oedema
por: Sen, Sagnik, et al.
Publicado: (2021)

Diabetic Macular Oedema Guidelines: An Australian Perspective
por: Yuen, Yew Sen, et al.
Publicado: (2023)

Impact of metabolic control on macular thickness in diabetic macular oedema
por: Peng, Yi-Jie, et al.
Publicado: (2017)

Characterisation of progression of macular oedema in the initial stages of diabetic retinopathy: a 3-year longitudinal study
por: Lobo, Conceição, et al.
Publicado: (2022)

A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening program
por: Vaghefi, Ehsan, et al.
Publicado: (2022)

External validation of cut-off points for foveal thickness taking into account the intraretinal fluid using optical coherence tomography to diagnose diabetic macular oedema
por: Hernández-Martínez, Carmen, et al.
Publicado: (2017)

Vitreoretinal interface abnormalities in patients treatedwith ranibizumab for diabetic macular oedema
por: Wong, Yun, et al.
Publicado: (2016)

Detection of diabetic macular oedema: validation of optical coherence tomography using both foveal thickness and intraretinal fluid
por: Hernández-Martínez, Carmen, et al.
Publicado: (2015)

Cognitive behavioral treatment to improve psychological adjustment in people recently diagnosed with type 2 diabetes: Psychological treatment in type 2 diabetes
por: Velázquez-Jurado, Héctor, et al.
Publicado: (2023)

Pseudophakic Cystoid Macular Oedema (PCME) Prevention in Patients with Non-Proliferative Diabetic Retinopathy (NPDR)—Randomized Controlled Trial
por: Jukić, Anđela, et al.
Publicado: (2022)

Aflibercept versus ranibizumab for treating persistent diabetic macular oedema
por: ROA Vandekerckhove, Kristof
Publicado: (2015)

Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema
por: Mateos-Olivares, Milagros, et al.
Publicado: (2021)

Macular thickness amplitude changes when switching from discontinuous to continuous therapy for diabetic macular oedema
por: Schechet, Sidney A, et al.
Publicado: (2019)

Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study
por: Zhuang, Xuenan, et al.
Publicado: (2019)

Validity of Optical Coherence Tomography as a Diagnostic Method for Diabetic Retinopathy and Diabetic Macular Edema
por: Azrak, Cesar, et al.
Publicado: (2015)

Surveillance of people with previously successfully treated diabetic macular oedema and proliferative diabetic retinopathy by trained ophthalmic graders: cost analysis from the EMERALD study
por: Maredza, Mandy, et al.
Publicado: (2022)

Patients views on a new surveillance pathway involving allied non-medical staff for people with treated diabetic macular oedema and proliferative diabetic retinopathy
por: Prior, Lindsay, et al.
Publicado: (2022)

Current treatments in diabetic macular oedema: systematic review and meta-analysis
por: Ford, John Alexander, et al.
Publicado: (2013)

Real Life Experience of Dexamethasone Implant in Refractory Diabetic Macular Oedema
por: Karttunen, Tommi, et al.
Publicado: (2019)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Proportion of people with diabetic retinopathy and macular oedema varies by ethnicity in a tertiary retinal clinic in Australia: findings from the Liverpool Eye and Diabetes Study (LEADS)
por: Liew, Gerald, et al.
Publicado: (2023)

Detection of sudomotor alterations evaluated by Sudoscan in patients with recently diagnosed type 2 diabetes
por: García-Ulloa, Ana Cristina, et al.
Publicado: (2022)

Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema
por: Chakravarthy, Usha, et al.
Publicado: (2019)

Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney)
por: Liew, Gerald, et al.
Publicado: (2019)

Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
por: Rechtman, Ehud, et al.
Publicado: (2007)

Effectiveness of Multimodal imaging for the Evaluation of Retinal oedema And new vesseLs in Diabetic retinopathy (EMERALD)
por: Lois, Noemi, et al.
Publicado: (2019)

Randomised trial of wide-field guided PRP for diabetic macular oedema treated with ranibizumab
por: Talks, S. James, et al.
Publicado: (2019)

Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
por: Massa, Horace, et al.
Publicado: (2018)

HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
por: Sharma, Sadhana, et al.
Publicado: (2020)

Burden Of Treatment Among Patients Undergoing Intravitreal Injections For Diabetic Macular Oedema In Australia
por: Spooner, Kimberly L, et al.
Publicado: (2019)

Change in choroidal volume after dexamethasone intravitreal implant in eyes with diabetic macular oedema
por: Posch‐Pertl, Laura, et al.
Publicado: (2018)

Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
por: Sabeti, Faran, et al.
Publicado: (2023)

Association of OCT biomarkers and visual impairment in patients with diabetic macular oedema with vitreomacular adhesion
por: Subramanian, Brughanya, et al.
Publicado: (2023)

Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion
por: Bhandari, Sanjeeb, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sjfvh9qelp5tlcni1ltg4a7832